General Range

Conistat-Gold 20

Novalab Cardiac Diabetic CarePanchkula, Haryana

Conistat-Gold 20 Capsules by Novalab Cardiac & Diabetic Care contain Rosuvastatin, Clopidogrel and Aspirin, a prescription cardiovascular combination formulated for cholesterol management and the prevention of certain cardiovascular complications in selected high-risk patients.

Rosuvastatin belongs to the statin class of lipid-lowering medicines. It works by inhibiting HMG-CoA reductase, an enzyme responsible for cholesterol synthesis in the liver. This action helps lower LDL cholesterol levels and reduce the risk of cardiovascular events associated with atherosclerosis.

Clopidogrel is an antiplatelet medicine that works by inhibiting the platelet P2Y12 receptor, reducing platelet activation and aggregation. Aspirin inhibits platelet cyclooxygenase-1 (COX-1), decreasing thromboxane A2 production and helping prevent platelet aggregation.

Together, Clopidogrel and Aspirin provide dual antiplatelet therapy, while Rosuvastatin helps manage cholesterol levels and reduce atherosclerotic cardiovascular risk.

Conistat-Gold 20 Capsules may be prescribed for selected patients with coronary artery disease, a previous myocardial infarction, acute coronary syndrome or following angioplasty and coronary stent placement when combined treatment is clinically appropriate.

The duration of treatment depends on the patient's cardiovascular condition, cholesterol levels, bleeding risk, medical history and response to therapy.

Conistat-Gold 20 Capsules should be taken strictly according to a registered medical practitioner's prescription. Patients should not discontinue antiplatelet therapy without consulting their cardiologist.

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.